Despite the boom in popularity of expensive GLP-1 drugs to treat weight loss, fewer than one in … [+] five large employers are covering such prescriptions, a new KFF analysis shows. In this photo is Ozempic, a GLP-1 for adults with type 2 diabetes that along with diet and exercise may improve blood sugar. (Photo […]